Filing Flows › Relay Therapeutics (RLAY) › Q2 2026 › vs Q1 2026
Relay Therapeutics (RLAY) Q2 2026 vs Q1 2026 (quarter over quarter)
Relay Therapeutics's revenue fell $2.6M (-88%) from $3.0M in Q1 2026 to $350K in Q2 2026.
Relay Therapeutics, Q2 2026: revenue $350K (-48% year over year), net loss $83.7M, operating cash flow −$54.1M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $350K | $3.0M | −$2.6M | -88% |
| Other income, net | $7.1M | $5.3M | $1.8M | +34% |
| Net loss | $83.7M | $73.3M | $10.4M | +14% |
| Costs & expenses | $91.2M | $81.6M | $9.6M | +12% |
| Operating costs | $91.2M | $81.6M | $9.6M | +12% |
| Research & development | $76.5M | $70.6M | $5.9M | +8% |
| General & admin | $14.7M | $11.0M | $3.7M | +33% |
| Operating cash sources | $83.7M | $73.3M | $10.4M | +14% |
| Depreciation | $360K | $504K | −$144K | -29% |
| Share-based compensation | $9.2M | $10.5M | −$1.4M | -13% |
| Working capital & other | $20.1M | $11.1M | $8.9M | +80% |
| Cash used in operations | $54.1M | $51.1M | $3.0M | +6% |
| Net loss absorbed | $83.7M | $73.3M | $10.4M | +14% |
Questions
How much did Relay Therapeutics's revenue grow quarter over quarter in Q2 2026?
Relay Therapeutics's revenue fell $2.6M (-88%) from $3.0M in Q1 2026 to $350K in Q2 2026.